MAST CELL ACTIVATION SYNDROME

This adverse event was reported 1404 times

These drugs are most commonly taken by patients reporting MAST CELL ACTIVATION SYNDROME:

# Drug Count
0 OMALIZUMAB 372
1 FAMOTIDINE 200
2 CETIRIZINE HYDROCHLORIDE 165
3 MONTELUKAST 137
4 DIPHENHYDRAMINE HYDROCHLORIDE 126
5 MONTELUKAST SODIUM 120
6 ALBUTEROL SULFATE 102
7 CETIRIZINE 96
8 PREDNISONE 92
9 LORATADINE 91
See all common drugs associated with MAST CELL ACTIVATION SYNDROME